AHL
IRWD icon

Abel Hall LLC’s Ironwood Pharmaceuticals IRWD Stock Holding History

Abel Hall LLC’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.6K Buy
13,450
+542
+4% +$2.09K 0.01% 893
2026
Q1 		$45.3K Sell
12,908
-3,753
-23% -$15.4K 0.01% 750
2025
Q4 		$56.1K Buy
+16,661
New +$43.3K 0.01% 651

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Abel Hall LLC's IRWD Position: Q2 2026 in Review

Abel Hall LLC increased its Ironwood Pharmaceuticals (IRWD) stake by 4.2% in Q2 2026, buying an estimated $2.09K and bringing the position to 13,450 shares worth $56.6K. The position accounts for 0.01% of the portfolio, ranked #893.

Abel Hall LLC first reported a position in IRWD in Q4 2025 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Abel Hall LLC held 13,450 shares of Ironwood Pharmaceuticals worth $56.6K as of Q2 2026.
  • Abel Hall LLC bought 542 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $2.09K.
  • Ironwood Pharmaceuticals made up 0.01% of Abel Hall LLC's portfolio in Q2 2026, its #893 holding.
  • Abel Hall LLC first reported a position in Ironwood Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.